A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Incyte Corporation
Incyte Corporation
J-Pharma Co., Ltd.
Centre Leon Berard
Sun Yat-sen University
University of Campania Luigi Vanvitelli
GlaxoSmithKline
Shanghai Zhongshan Hospital
Centre Hospitalier Universitaire Dijon
Azienda Ospedaliera Universitaria Integrata Verona
Seoul National University Hospital
Fudan University
Sixth Affiliated Hospital, Sun Yat-sen University
Sixth Affiliated Hospital, Sun Yat-sen University
Sun Yat-sen University
Catharina Ziekenhuis Eindhoven
Sun Yat-sen University
Tanta University